Lannett Company (NYSE:LCI) launched Cediprof Inc.’s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusive supply and distribution agreement.
Cediprof, Inc. is a part of the Neolpharma Pharmaceutical Group family of companies.
LCI also said they have prevailed in separate legal challenges by Cediprof’s previous distributor of the product.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.